Latha Vairavan, SVP Chief Financial Officer at Arcutis Biotherapeutics, Inc. (ARQT), sold 5,706 shares at $25.16 ($144K) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Open-market sale of $144k ARQT by SVP Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.16 | 2,772 | $70K | 48.5% |
| 2 | $25.16 | 2,772 | $70K | 48.5% |
| 3 | $25.91 | 81 | $2K | 1.5% |
| 4 | $25.91 | 81 | $2K | 1.5% |
| Total | $25.18 avg | 5,706 | $144K | 100% |
| Filing → |
| ARQT | SELL | 2026-02-04 | $34K | — | Filing → |
| ARQT | SELL | 2025-11-05 | $2K | — | Filing → |
| ARQT | SELL | 2025-08-05 | $1K | — | Filing → |